Sonoma Pharmaceuticals, Inc.
(NASDAQ : SNOA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 3.27%29.0714.1%$171.05m
ICLRICON plc 0.93%229.204.2%$156.70m
JAZZJazz Pharmaceuticals Plc 0.57%179.172.2%$142.15m
HZNPHorizon Therapeutics Plc 5.02%92.145.5%$124.53m
CTLTCatalent, Inc. 2.18%102.672.1%$105.63m
BHCBausch Health Cos., Inc. 3.27%29.070.0%$91.68m
SAVACassava Sciences, Inc. 8.31%40.920.0%$55.78m
UTHRUnited Therapeutics Corp. 2.12%197.8714.0%$55.65m
PRGOPerrigo Co. Plc 1.80%45.826.9%$49.71m
BLRXBioLineRx Ltd. 0.00%2.850.8%$38.97m
ARGXargenx SE 4.22%272.300.0%$38.23m
SAGESAGE Therapeutics, Inc. 2.03%70.867.6%$33.60m
PCRXPacira Biosciences, Inc. 1.22%62.219.9%$30.64m
AXSMAxsome Therapeutics, Inc. -2.68%58.421.9%$26.79m
RVMDRevolution Medicines, Inc. 4.07%31.990.0%$23.38m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA.